Use of OCTA Capillary Perfusion Density Measurements to Detect and Grade Macular Ischemia
Amy Babiuch(Cleveland Clinic), Justis P. Ehlers(Cleveland Clinic), Aleksandra Rachtiskaya(Cleveland Clinic), Atsuro Uchida(Keio University), Sunil K. Srivastava(Cleveland Clinic), Rishi P. Singh(Massachusetts Eye and Ear Infirmary), Mehnaz Khan(Cleveland Clinic), Ming Hu(Shihezi University), Jamie Reese(Advanced Imaging Research (United States)), Peter K. Kaiser(Cleveland Clinic)
Cited by 3
Related Papers
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
|The Lancet|2023|343
Phenotype of atopic dermatitis subjects with a history of eczema herpeticum
|Journal of Allergy and Clinical Immunology|2009|264
CTCF mediates dosage- and sequence-context-dependent transcriptional insulation by forming local chromatin domains
|Nature Genetics|2021|203
TENAYA and LUCERNE
|Ophthalmology|2024|173
Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration
|British Journal of Ophthalmology|2014|99